For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was $9.34 for the day, down -1.16% from the previous closing price of $9.45. In other words, the price has decreased by -$1.16 from its previous closing price. On the day, 1.22 million shares were traded. PHAT stock price reached its highest trading level at $9.98 during the session, while it also had its lowest trading level at $8.965.
Ratios:
Our analysis of PHAT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.68 and its Current Ratio is at 5.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 03, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
On January 05, 2024, Needham reiterated its Buy rating and also lowered its target price recommendation from $23 to $26.
On August 09, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $28.H.C. Wainwright initiated its Buy rating on August 09, 2023, with a $28 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 15 ’24 when Nabulsi Azmi sold 10,901 shares for $11.72 per share. The transaction valued at 127,760 led to the insider holds 240,421 shares of the business.
Henderson Molly sold 4,325 shares of PHAT for $50,689 on Jul 15 ’24. The CFO and CBO now owns 99,447 shares after completing the transaction at $11.72 per share. On Jul 15 ’24, another insider, Curran Terrie, who serves as the President and Chief Executive of the company, sold 33,848 shares for $11.72 each. As a result, the insider received 396,699 and left with 377,734 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHAT now has a Market Capitalization of 638644928 and an Enterprise Value of 822958528. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.03. Its current Enterprise Value per Revenue stands at 31.327 whereas that against EBITDA is -2.866.
Stock Price History:
Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $6.07. The 50-Day Moving Average of the stock is -40.33%, while the 200-Day Moving Average is calculated to be -23.43%.
Shares Statistics:
PHAT traded an average of 1.34M shares per day over the past three months and 2870850 shares per day over the past ten days. A total of 57.97M shares are outstanding, with a floating share count of 34.85M. Insiders hold about 49.04% of the company’s shares, while institutions hold 69.14% stake in the company. Shares short for PHAT as of 1730332800 were 17450062 with a Short Ratio of 13.04, compared to 1727654400 on 17219985. Therefore, it implies a Short% of Shares Outstanding of 17450062 and a Short% of Float of 36.060002000000004.
